Delivery Order SPE2DB25D3008-SPE2DB25FRDAP
- Not listed
- The Defense Logistics Agency awarded a $1,706.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 10 mg capsules (100 count) on August 1, 2025, with an ultimate completion date of August 4, 2025. This non-set-aside contract was performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's broader pharmaceutical supply relationship with the DLA. This award is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,401.40 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lisdexamfetamine 30 mg capsules (100 count). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 29, 2025. The contract is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency has awarded a delivery order valued at $1,610.40 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100-count units). This competitively awarded, firm fixed-price contract was executed on August 5, 2025, with an ultimate completion date of August 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 40 mg capsules (100-count) valued at $2,057.66. The contract, which closed on August 28, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be fulfilled from the contractor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,573.66 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 20 mg capsules (100-count units) on August 19, 2025, with completion targeted for August 20, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's corporate facility in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,883.72 for Lisdexamfetamine 30 mg capsules (100-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order under the company's broader pharmaceutical supply arrangements with DLA. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $1.82K to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 70 mg capsules (100-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,262.11 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 70 mg capsules (100-count units). The award was made on September 3, 2025, under firm fixed pricing with an ultimate completion date of September 4, 2025. This non-set-aside, competitively awarded delivery order will be performed at the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,760.99 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 50 mg capsules (90-count). The contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100 count) under a firm fixed-price contract with a ceiling value of $2,136.69. The award, effective September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- SPE2DB25D3008Indefinite Delivery Contract
- SPE2DB25D3008-SPE2DB25FRDAPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,977.61 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100 count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order was issued under a child contract arrangement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables comprehensive global pharmaceutical support across military healthcare systems and serves as a flexible mechanism for supplying a broad range of pharmaceutical products, medical devices, and healthcare commodities. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role in supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare programs with diverse medication and medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/22/25 |